Dispatches from FIE 2011

Oat beta glucan makes claims on European cholesterol market

By Shane Starling in Paris

- Last updated on GMT

Related tags: European union, Managing director, Corporate governance

The European Union cholesterol-lowering market has a new player after an oat beta glucan's claim was written in to European law books this month.

Ruedi Duss, the managing director of CreaNutrition, the Swiss-Swedish oat beta glucan specialist behind the claim, told NutraIngredients what it means to have won a rare article 14 disease risk factor reduction claim: After a few millions of euros of investment, it means a lot.

Related news

Show more

Related products

show more

Robertet, hemp extracts and CBD solutions

Robertet, hemp extracts and CBD solutions

Robertet Health & Beauty | 27-May-2021 | Product Brochure

Robertet was the first flavor & fragrance company to venture into the CBD space. We have over 3 years of expertise working with this unique ingredient...

REVOLUTIONARY PRODUCT for CHRONIC KIDNEY DISEASE

REVOLUTIONARY PRODUCT for CHRONIC KIDNEY DISEASE

THINQ Pharma-CRO Pte Ltd | 17-May-2021 | Clinical Study

IS THERE AN ORALLY CONSUMABLE PRODUCT USEFUL FOR DECREASING SERUM CREATININE LEVEL, DECREASE IN BLOOD UREA NITROGEN, INCREASING eGLOMARULAR FILTRATION...

Related suppliers

Follow us

Products

View more

Webinars